“…With the promotion of high-sensitivity cTn (hs-cTn) testing, its clinical application in children is also more extensive. In pediatric CHD, hs-cTn may provide a better prognostic value when compared to an adult population ( 7 ). Unfortunately, there are limited data on high-sensitivity cTnI (hs-cTnI) in healthy newborns, children, and adolescents, leading most laboratories to take reference of adult-based cutoff values to interpret the results.…”